AAO: Sequential nonarteritic anterior ischemic optic neuropathy occurs earlier with GLP-1 receptor agonist exposure

A study presented at the American Academy of Ophthalmology found that patients with NAION who had GLP-1 receptor agonist exposure experienced sequential NAION earlier than nonusers. Researchers observed a higher concentration of second-eye events within six months among GLP-1 users, though further investigation is needed.